Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Oppliger Leibundgut

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Genetics|February 1, 1996
Identification of four novel splice site mutations in the ornithine transcarbamylase geneE Oppliger Leibundgut, B Wermuth, J P Colombo, et al.
Human Mutation|January 1, 1997
Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous femalesE Oppliger Leibundgut, S Liechti-Gallati, J P Colombo, et al.
Cytotherapy|October 30, 2004
Real-time process/quality control for HPC processingM Arpagaus, E Oppliger Leibundgut, K Zbären, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Pleural tumors as sole primary manifestation of acute promyelocytic leukemiaB U Mueller, A U Buerger, M Solenthaler, et al.
Leukemia|February 6, 2015
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemiaN C P Cross, H E White, D Colomer, et al.
Leukemia|February 14, 2015
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IVL Kalmanti, S Saussele, M Lauseker, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Genetics|February 1, 1996
Identification of four novel splice site mutations in the ornithine transcarbamylase geneE Oppliger Leibundgut, B Wermuth, J P Colombo, et al.
Human Mutation|January 1, 1997
Ornithine transcarbamylase deficiency: ten new mutations and high proportion of de novo mutations in heterozygous femalesE Oppliger Leibundgut, S Liechti-Gallati, J P Colombo, et al.
Cytotherapy|October 30, 2004
Real-time process/quality control for HPC processingM Arpagaus, E Oppliger Leibundgut, K Zbären, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Pleural tumors as sole primary manifestation of acute promyelocytic leukemiaB U Mueller, A U Buerger, M Solenthaler, et al.
Leukemia|February 6, 2015
Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemiaN C P Cross, H E White, D Colomer, et al.
Leukemia|February 14, 2015
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IVL Kalmanti, S Saussele, M Lauseker, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
Pageof 1